Palisade Bio (PALI) Invested Capital (2010 - 2026)
Palisade Bio (PALI) reported Invested Capital of $127.4 million for Q1 2026, up 2258.56% year-over-year from $5.4 million in Q1 2025, and down 1.56% on a QoQ basis from $129.4 million in Q4 2025.
Palisade Bio (PALI) has 17 years of Invested Capital data on file, last reported at $127.4 million in Q1 2026.
- Quarterly Invested Capital rose 2258.56% year-over-year to $127.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.4 million (up 2258.56% YoY) and the FY2025 annual result came in at $129.4 million, up 1626.91% from the prior year.
- Invested Capital fell to $127.4 million in Q1 2026 per PALI's latest filing, from $129.4 million in the prior quarter.
- Across five years, Invested Capital topped out at $129.4 million in Q4 2025 and bottomed at $2.7 million in Q2 2025.
- The 5-year median for Invested Capital is $10.2 million (2024), against an average of $23.0 million.
- The widest annual swing landed in 2025, when Invested Capital sank 73.4%; it then surged 2258.56% in 2026.
- Tracing PALI's Invested Capital over 5 years: stood at $12.5 million in 2022, then fell by 8.2% to $11.5 million in 2023, then sank by 34.6% to $7.5 million in 2024, then soared by 1626.91% to $129.4 million in 2025, then declined by 1.56% to $127.4 million in 2026.
- Per Business Quant, the three latest PALI Invested Capital figures stand at $127.4 million (Q1 2026), $129.4 million (Q4 2025), and $3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 127.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.36 Mn |
| Dec 31, 2025 | 129.38 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 7.49 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 10.10 Mn |
| Mar 31, 2024 | 10.21 Mn |
| Dec 31, 2023 | 11.46 Mn |
| Sep 30, 2023 | 14.08 Mn |
| Jun 30, 2023 | 15.80 Mn |
| Mar 31, 2023 | 13.75 Mn |
| Dec 31, 2022 | 12.48 Mn |
| Sep 30, 2022 | 12.43 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 4.79 Mn |
| Dec 31, 2021 | 7.45 Mn |
| Sep 30, 2021 | 3.92 Mn |
| Jun 30, 2021 | -8.30 Mn |
| Mar 31, 2021 | -20.06 Mn |
| Dec 31, 2020 | -15.46 Mn |
| Sep 30, 2020 | -12.85 Mn |
| Jun 30, 2020 | -11.68 Mn |
| Mar 31, 2020 | -10.23 Mn |
| Dec 31, 2019 | -8.33 Mn |
| Sep 30, 2019 | 7.04 Mn |
| Jun 30, 2019 | 1.96 Mn |
| Mar 31, 2019 | 3.27 Mn |
| Dec 31, 2018 | 6.05 Mn |
| Sep 30, 2018 | 4.48 Mn |
| Jun 30, 2018 | 6.18 Mn |
| Mar 31, 2018 | 6.61 Mn |
| Dec 31, 2017 | 8.52 Mn |
| Sep 30, 2017 | 11.56 Mn |
| Jun 30, 2017 | 7.69 Mn |
| Mar 31, 2017 | 12.32 Mn |
| Dec 31, 2016 | 15.10 Mn |
| Sep 30, 2016 | -2.60 Mn |
| Jun 30, 2016 | 3.18 Mn |
| Mar 31, 2016 | 4.30 Mn |
| Dec 31, 2015 | 9.51 Mn |
| Sep 30, 2015 | 13.36 Mn |
| Jun 30, 2015 | 17.71 Mn |
| Mar 31, 2015 | 21.29 Mn |
| Dec 31, 2014 | 18.45 Mn |
| Sep 30, 2014 | 20.90 Mn |
| Jun 30, 2014 | 26.98 Mn |
| Mar 31, 2014 | 29.75 Mn |
| Dec 31, 2013 | 11.18 Mn |
| Sep 30, 2013 | 9.58 Mn |
| Jun 30, 2013 | 5.65 Mn |
| Mar 31, 2013 | 6.20 Mn |
| Dec 31, 2012 | 6.97 Mn |
| Sep 30, 2012 | 9.10 Mn |
| Jun 30, 2012 | 2.49 Mn |
| Mar 31, 2012 | 4.53 Mn |
| Dec 31, 2011 | 1.66 Mn |
| Sep 30, 2011 | 3.90 Mn |
| Jun 30, 2011 | 6.27 Mn |
| Dec 31, 2010 | 9.11 Mn |